• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阈下577纳米微脉冲激光治疗中心性浆液性脉络膜视网膜病变。

Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy.

作者信息

Maruko Ichiro, Koizumi Hideki, Hasegawa Taiji, Arakawa Hisaya, Iida Tomohiro

机构信息

Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Shinjuku, Tokyo, Japan.

出版信息

PLoS One. 2017 Aug 29;12(8):e0184112. doi: 10.1371/journal.pone.0184112. eCollection 2017.

DOI:10.1371/journal.pone.0184112
PMID:28850595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5574536/
Abstract

PURPOSE

To compare the efficacy of the subthreshold micropulse laser (SML) to conventional laser (CL) in treating focal leakages of the retinal pigment epithelium (RPE) in the eyes with central serous chorioretinopathy (CSC).

METHODS

Twenty-nine eyes of 28 patients with CSC and typical focal leakage were treated with CL or SML. Both treatments were made with a 577 nm yellow laser (CL: NIDEK MC-500, SML: IRIDEX IQ577). The percentage of eyes with a complete resolution, the distance of the laser burns from the fovea, and injury of the RPE after treatment were studied.

RESULTS

A complete resolution was seen in 10 of 15 eyes (66.7%) after CL and 9 of 14 eyes (64.3%) after SML (P = 0.89). The average distance from the foveal center to the leakage point was 1282±596 μm for eyes treated with CL and 1271±993 μm for eyes treated with SML (P = 0.4). Only three eyes treated with SML had treatment sites within 500 μm of the fovea. RPE damage determined by fundus autofluorescence was found in all eyes treated with CL and only one eye treated with SML (P<.01).

CONCLUSIONS

SML achieved equivalent therapeutic effects as CL but without RPE damage in eyes with CSC.

摘要

目的

比较阈下微脉冲激光(SML)与传统激光(CL)治疗中心性浆液性脉络膜视网膜病变(CSC)患者视网膜色素上皮(RPE)局灶性渗漏的疗效。

方法

对28例患有CSC且有典型局灶性渗漏的患者的29只眼进行CL或SML治疗。两种治疗均使用577 nm黄色激光(CL:NIDEK MC - 500,SML:IRIDEX IQ577)。研究完全消退的眼的百分比、激光烧灼点距黄斑中心凹的距离以及治疗后RPE的损伤情况。

结果

CL治疗后15只眼中有10只(66.7%)完全消退,SML治疗后14只眼中有9只(64.3%)完全消退(P = 0.89)。接受CL治疗的眼从黄斑中心到渗漏点的平均距离为1282±596μm,接受SML治疗的眼为1271±993μm(P = 0.4)。仅3只接受SML治疗的眼的治疗部位在距黄斑中心凹500μm范围内。通过眼底自发荧光确定的RPE损伤在所有接受CL治疗的眼中均有发现,而在接受SML治疗的眼中仅1只眼出现(P<0.01)。

结论

在CSC患者中,SML与CL取得了同等的治疗效果,但未造成RPE损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259a/5574536/a48132ba98b5/pone.0184112.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259a/5574536/448e525a7cf2/pone.0184112.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259a/5574536/a48132ba98b5/pone.0184112.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259a/5574536/448e525a7cf2/pone.0184112.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/259a/5574536/a48132ba98b5/pone.0184112.g002.jpg

相似文献

1
Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy.阈下577纳米微脉冲激光治疗中心性浆液性脉络膜视网膜病变。
PLoS One. 2017 Aug 29;12(8):e0184112. doi: 10.1371/journal.pone.0184112. eCollection 2017.
2
The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.阈下微脉冲黄色激光(577nm)治疗慢性中心性浆液性脉络膜视网膜病变的疗效。
Lasers Med Sci. 2021 Jul;36(5):981-988. doi: 10.1007/s10103-020-03129-5. Epub 2020 Aug 19.
3
Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者亚阈值微脉冲激光(577nm)治疗与半剂量光动力疗法的比较
Eye (Lond). 2016 Oct;30(10):1371-1377. doi: 10.1038/eye.2016.142. Epub 2016 Jul 8.
4
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.阈下微脉冲黄光激光(577纳米)光凝治疗慢性中心性浆液性脉络膜视网膜病变的短期疗效
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2129-35. doi: 10.1007/s00417-015-2965-7. Epub 2015 Feb 26.
5
Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: A meta-analysis.亚阈值微脉冲激光治疗慢性中心性浆液性脉络膜视网膜病变的疗效:一项荟萃分析。
Photodiagnosis Photodyn Ther. 2022 Sep;39:102931. doi: 10.1016/j.pdpdt.2022.102931. Epub 2022 May 27.
6
Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial.阈下微脉冲激光与传统激光治疗中心性浆液性脉络膜视网膜病变的随机对照临床试验
Front Med (Lausanne). 2021 Jul 16;8:682264. doi: 10.3389/fmed.2021.682264. eCollection 2021.
7
Prognostic factors of visual outcome in central serous chorioretinopathy treated with subthreshold micropulse laser therapy.经阈下微脉冲激光治疗的中心性浆液性脉络膜视网膜病变的预后因素。
Lasers Med Sci. 2024 Oct 10;39(1):256. doi: 10.1007/s10103-024-04207-8.
8
Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.经阈下微脉冲激光治疗的慢性中心性浆液性脉络膜视网膜病变患者的功能和形态学转归
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2299-2306. doi: 10.1007/s00417-017-3783-x. Epub 2017 Aug 22.
9
Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.慢性中心性浆液性脉络膜视网膜病变中的阈下微脉冲黄色激光(577纳米):安全性和治疗效果
Eye (Lond). 2015 Feb;29(2):258-64; quiz 265. doi: 10.1038/eye.2014.315. Epub 2015 Jan 23.
10
Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.低强度/高密度阈下微脉冲二极管激光治疗慢性中心性浆液性脉络膜视网膜病变
Retina. 2015 Mar;35(3):532-6. doi: 10.1097/IAE.0000000000000285.

引用本文的文献

1
The safe lowest effective power of subthreshold micropulse laser treatment in Chinese patients with acute or chronic central serous chorioretinopathy.阈下微脉冲激光治疗中国急性或慢性中心性浆液性脉络膜视网膜病变患者的安全最低有效功率
Front Med (Lausanne). 2024 Nov 6;11:1494402. doi: 10.3389/fmed.2024.1494402. eCollection 2024.
2
Subthreshold Micropulse Laser (577 nm) Therapy with an Individual Approach for Power Titration in Patients with Chronic Central Serous Chorioretinopathy (Pilot Study).慢性中心性浆液性脉络膜视网膜病变患者采用个体化功率滴定的阈下微脉冲激光(577nm)治疗(初步研究)
J Ophthalmol. 2024 Oct 8;2024:9750395. doi: 10.1155/2024/9750395. eCollection 2024.
3

本文引用的文献

1
A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders.阈下微脉冲激光治疗黄斑疾病的综述
Adv Ther. 2017 Jul;34(7):1528-1555. doi: 10.1007/s12325-017-0559-y. Epub 2017 May 24.
2
Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.低能量光动力疗法与阈下微脉冲黄光波长激光治疗慢性中心性浆液性脉络膜视网膜病变的比较
J Ophthalmol. 2016;2016:3513794. doi: 10.1155/2016/3513794. Epub 2016 Aug 15.
3
Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
Subthreshold Micropulse Laser Versus Oral Spironolactone in Chronic Central Serous Chorioretinopathy: A Quasi-Randomized Controlled Trial.
亚阈微脉冲激光与口服螺内酯治疗慢性中心性浆液性脉络膜视网膜病变的随机对照研究。
Transl Vis Sci Technol. 2024 Aug 1;13(8):19. doi: 10.1167/tvst.13.8.19.
4
Continuous Laser Versus Micropulse Laser in the Treatment of Central Serous Chorioretinopathy: A Retrospective Study.连续激光与微脉冲激光治疗中心性浆液性脉络膜视网膜病变的回顾性研究
Cureus. 2024 Feb 7;16(2):e53799. doi: 10.7759/cureus.53799. eCollection 2024 Feb.
5
Selective retina therapy with real-time feedback-controlled technology in central serous chorioretinopathy: a 24-month follow-up real-world prospective study.实时反馈控制技术在中心性浆液性脉络膜视网膜病变中的选择性视网膜治疗:24 个月随访的真实世界前瞻性研究。
BMJ Open Ophthalmol. 2024 Jan 22;9(1):e001517. doi: 10.1136/bmjophth-2023-001517.
6
Micropulse Laser Therapy as an Integral Part of Eye Disease Management.微脉冲激光治疗作为眼病管理的一个组成部分。
Medicina (Kaunas). 2023 Jul 28;59(8):1388. doi: 10.3390/medicina59081388.
7
Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.黄色阈下微脉冲激光治疗视网膜疾病:文献的深入分析与综述
Ophthalmol Ther. 2023 Jun;12(3):1479-1500. doi: 10.1007/s40123-023-00698-w. Epub 2023 Mar 18.
8
Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.两种亚阈微脉冲黄光激光治疗方案治疗未消退中心性浆液性脉络膜视网膜病变的比较。
Indian J Ophthalmol. 2022 Sep;70(9):3341-3345. doi: 10.4103/ijo.IJO_228_22.
9
Subthreshold laser therapy guidelines for retinal diseases.视网膜疾病的阈下激光治疗指南。
Eye (Lond). 2022 Dec;36(12):2234-2235. doi: 10.1038/s41433-022-02136-w. Epub 2022 Jun 23.
10
Short-term comparison between navigated subthreshold microsecond pulse laser and oral eplerenone for chronic central serous chorioretinopathy.导航亚阈值微秒脉冲激光与口服依普利酮治疗慢性中心性浆液性脉络膜视网膜病变的短期比较。
Sci Rep. 2022 Mar 18;12(1):4727. doi: 10.1038/s41598-022-08764-2.
慢性中心性浆液性脉络膜视网膜病变患者亚阈值微脉冲激光(577nm)治疗与半剂量光动力疗法的比较
Eye (Lond). 2016 Oct;30(10):1371-1377. doi: 10.1038/eye.2016.142. Epub 2016 Jul 8.
4
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析。
Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD011841. doi: 10.1002/14651858.CD011841.pub2.
5
Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy.阈下微脉冲黄光激光治疗非消退型中心性浆液性脉络膜视网膜病变
Clin Ophthalmol. 2015 Dec 3;9:2277-83. doi: 10.2147/OPTH.S87499. eCollection 2015.
6
Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.慢性中心性浆液性脉络膜视网膜病变中的阈下微脉冲黄色激光(577纳米):安全性和治疗效果
Eye (Lond). 2015 Feb;29(2):258-64; quiz 265. doi: 10.1038/eye.2014.315. Epub 2015 Jan 23.
7
Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema.纯黄光(577纳米)和810纳米阈下微脉冲激光光凝联合黄光(561 - 577纳米)直接光凝治疗糖尿病性黄斑水肿的疗效比较
Jpn J Ophthalmol. 2015 Jan;59(1):21-8. doi: 10.1007/s10384-014-0361-1. Epub 2014 Nov 14.
8
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.医学统计学中免费易用软件 EZR 的调查研究。
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi: 10.1038/bmt.2012.244. Epub 2012 Dec 3.
9
Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.亚阈值二极管激光微脉冲光凝与玻璃体内注射贝伐单抗治疗中心性浆液性脉络膜视网膜病变。
Eye (Lond). 2012 Feb;26(2):307-14. doi: 10.1038/eye.2011.282. Epub 2011 Nov 11.
10
Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.阈下二极管微脉冲光凝术治疗伴有黄斑旁渗漏的慢性中心性浆液性脉络膜视网膜病变
Ophthalmology. 2008 Dec;115(12):2229-34. doi: 10.1016/j.ophtha.2008.08.026.